glipizide


Also found in: Thesaurus, Medical, Wikipedia.

glip·i·zide

 (glĭp′ĭ-zīd′)
n.
A sulfonylurea drug, C21H27N5O4S, used to treat type 2 diabetes.

[gli-, pref. for drugs used to control hyperglycemia (variant of gly-; see glyburide) + alteration of py(ra)z(ine) + (am)ide.]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.glipizide - an oral antidiabetic drug (trade name Glucotrol) that stimulates the release of insulin from the pancreas
antidiabetic, antidiabetic drug - a drug used to treat diabetes mellitus
Translations

glipizide

n glipizida
References in periodicals archive ?
On the other hand, glimepiride (Amaryl), glipizide (Glucotrol), and glyburide (Diabeta, Micronase) do not appear to lower cardiovascular risk.
Her parents report that one of them has diabetes and takes oral hypoglycemic agents at home, including glipizide immediate release (IR) tablets, 10 mg, and long-acting insulin glargine.
He is currently on metformin, glipizide, and warfarin sodium.
(10) Glipizide has no active metabolites and has the lowest risk of hypoglycemia in the setting of decreased renal function, making it the preferred sulfonylurea for use in the elderly.
Summary: A simple, rapid, and sensitive HPLC-PDA method has been developed for the simultaneous separation and estimation of metformin (MET), sitagliptin (SIT), glipizide (GPZ), and glibenclamide (GBN).
Other Options If metformin doesn't lower your blood sugar sufficiently, other older drugs may be used with it--for example, glipizide (Glucotrol), or glimepiride (Amaryl).
Despite supportive care and oral glipizide, the goose died within 48 hours of presentation.
There has been some breakthrough in the management and treatment of this diabetes such as the use of glimepiride, acarbose, alogliptin, canagliflozin, glipizide, glimepiride, empagliflozin, dapagliflozin, colesevelam and sometimes a combination of medication.
Meier et al., "Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial," Diabetes Care, vol.
These included tacrolimus, prednisone, sulfamethoxazole/trimethoprim (TMP-SMZ), metformin, glipizide, and propranolol.
SGLT2i (+MET) versus SU (+MET) Percentage of patients with NSHEs in SU arm (%) Dapagliflozin versus glipizide [19] 39 Canagliflozin versus glimepiride [21] 31 Empagliflozin versus glimepiride [23] 20 SGLT2i (+MET) versus SU (+MET) Percentage of patients with NSHEs in SGLT2i arm (%) Dapagliflozin versus glipizide [19] 3.4 Canagliflozin versus glimepiride [21] 5 Empagliflozin versus glimepiride [23] 1.5 Table 2: Costs associated with nonsevere hypoglycemic episodes (NSHEs) per episode from literature.